We are monitoring the impact of COVID-19 on Asia Pacific Perfusion Systems Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Perfusion Systems Market Research Report - Segmented By Component, Type, Technique & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecast To 2027

Published: January, 2022
ID: 3412
Pages: 145

Asia Pacific Perfusion Systems Market Size & Growth (2022 to 2027):

According to the report, the Size of the Perfusion Systems Market in Asia Pacific is valued at USD 0.25 billion in 2022 and projected to grow at a CAGR of 2.9%, to reach USD 0.28 billion by 2027 during the forecast period 2022 to 2027.

A primary driver propelling market expansion is the rising need for organ transplants due to the increasing prevalence of chronic diseases. Furthermore, as most organ failure rises, so does the demand for cost-effective solutions. Other organs, such as the liver, are currently being researched for transplantation. Changing societal habits and an aging population is mostly to blame for the rise in costly and common long-term chronic health conditions. Due to rapid urbanization and rising middle-class income, people choose a seated lifestyle.

Perfusion is the process of oxygenated blood being delivered to the rest of the body's tissues. Perfusion systems are used during organ transplant surgeries to let blood flow via a web of minuscule capillaries within the body's tissues, allowing oxygen and other vital chemicals to pass through semipermeable microvascular walls. The market is predicted to grow as patients requiring cardiovascular, renal, and hepatic transplants rise. Innovative technology allows for the safe storage and transplantation of organs from one person to another.

The Organ Care System (OCS) Heart keeps a donor's heart pumping until it's replanted in the receptor's body in a near-norm thermic environment. Growing government activities promoting organ donation and transplantation have resulted in a rise in organ transplant cases.

The high cost of organ transplantation, ethical issues, and the high price of cell-based research is projected to hinder the global perfusion systems market over the forecast period. On the other hand, government and non-governmental organizations (NGOs) encouraging organ donation, increasing expenditures for cell-based research, and increasing biologics manufacturing are all driving the Asia Pacific perfusion systems market forward. Therefore, the primary market challenge is the organ supply-demand gap.

This research report on the Asia Pacific Perfusion Systems Market has been segmented and sub-segmented into the following categories

By Component:

  • Heart-lung Machines
  • Perfusion Pumps
  • Oxygenators
  • Monitoring Systems
  • Cannulas

By Type:

  • Bioreactor Perfusion Systems
  • Microfluidic Perfusion Systems
  • Gravity/Pressure-driven Perfusion Systems
  • Small-mammal Organ Perfusion Systems

By Technique:

  • Hypothermic Machine Perfusion Systems
  • Normothermic Machine Perfusion Systems

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Asia is predicted to increase at the quickest rate during the forecast period. An increase in the burgeoning biotechnology industry and a growth in pharmaceutical and biotechnology R&D activities in Asia are expected to drive market expansion in the area. In addition, the rising prevalence of the growing geriatric population, and government initiatives to raise awareness, are all moving the market forward. The ever-increasing demand for human body part transplantation can be attributed to the rising prevalence of diseases, which has fueled the rise of the perfusion system sector. Organ failure is more common in people over the age of sixty.

Furthermore, the rise in the frequency of organ failures necessitates the development of cost-effective organ preservation technologies. On the other side, Asia Pacific has a low adoption of perfusion technologies. There was much focus on managing the covid-19, which diverted attention away from routine surgical procedures during this pandemic. Furthermore, the introduction of COVID-19 has put tremendous strain on currently available instrumentation, which is essential for perfusion. Again, the medical perfusion technology market is expected to be negatively impacted by the fall in organ transplantation and cell-based research activities.

KEY MARKET PLAYERS

Top Companies dominating the Asia Pacific Perfusion Systems Market Profiled in the Report are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, XENIOS AG, Repligen Corporation, Spectrum Laboratories, Inc, Merck KGaA, Harvard Bioscience, Inc, ALA Scientific Instruments, Inc.,

1.Introduction         

                1.1 Market Definition     

                1.2 Study Deliverables   

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions 

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases       

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary 

                3.2 Key Inferences

                3.3 Epidemiology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints     

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Component 

                                5.1.1 Heart-lung Machines                                          

                                5.1.2 Perfusion Pumps                                  

                                5.1.3 Oxygenators                                          

                                5.1.4 Monitoring Systems                                            

                                5.1.5 Cannulas                                  

                                5.1.6 Other Components                                             

                                5.1.7  Y-o-Y Growth Analysis, By Component                                      

                                5.1.8  Market Attractiveness Analysis, By Component                                    

                                5.1.9  Market Share Analysis, By Component                                      

                5.2 Type     

                                5.2.1 Bioreactor Perfusion Systems                                         

                                5.2.2 Microfluidic Perfusion Systems                                      

                                5.2.3 Gravity/Pressure-driven Perfusion Systems                                            

                                5.2.4 Small-mammal Organ Perfusion Systems                                  

                                5.2.5 Y-o-Y Growth Analysis, By Type                                     

                                5.2.6 Market Attractiveness Analysis, By Type                                   

                                5.2.7 Market Share Analysis, By Type                                     

                5.3 Technique    

                                5.3.1 Hypothermic Machine Perfusion Systems                                 

                                5.3.2 Normothermic Machine Perfusion Systems                                             

                                5.3.4 Y-o-Y Growth Analysis, By Technique                                          

                                5.3.5  Market Attractiveness Analysis, By Technique                                       

                                5.3.6  Market Share Analysis, By Technique                                         

6. Geographical Analysis                     

                6.1 Introduction      

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

   6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Component                

                                                6.1.3.3 By Type

                                                6.1.3.4 By Technique                     

                                6.1.4  Market Attractiveness Analysis                                     

  6.1.4.1 By Geographical Area                     

  6.1.4.2 By Component                  

  6.1.4.3 By Type                 

  6.1.4.4 By Technique                     

                                6.1.5  Market Share Analysis                                      

6.1.5.1 By Geographical Area                     

6.1.5.2 By Component                  

6.1.5.3 By Type                 

6.1.5.4 By Technique                     

                6.2 China    

                6.3 India     

                6.4 Japan   

                6.5 South Korea      

                6.6 Australia       

7.Strategic Analysis               

                7.1 PESTLE analysis

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis     

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                

                8.1 AB (Sweden)    

                                8.1.1 Overview                                 

                                8.1.2 Component Analysis                                           

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Medtronic plc (Ireland),         

                8.3 LivaNova PLC (U.K.) 

                8.4 Terumo Corporation (Japan)      

                8.5 XENIOS AG (Germany) 

                8.6 ALA Scientific Instruments, Inc. (U.S.)    

                8.7 Repligen Corporation (U.S.) 

                8.8 Spectrum Laboratories, Inc. (U.S.)     

                8.9 Merck KGaA (Germany)        

                8.10 Harvard Bioscience, Inc. (U.S.)

9.Competitive Landscape                   

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, Collaborations, and Joint Ventures

                9.4 New Product Launches

10.Market Outlook and Investment Opportunities                 

Appendix                  

                a) List of Tables 

                b) List of Figures     

  1. Asia-Pacific Perfusion Systems Market By Component, From 2022 - 2027 ( USD Billion )
  2. Asia-Pacific Heart-lung Machines Market By Region, From 2022 - 2027 ( USD Billion )
  3. Asia-Pacific Perfusion Pumps Market By Region, From 2022 - 2027 ( USD Billion )
  4. Asia-Pacific Oxygenators Market By Region, From 2022 - 2027 ( USD Billion )
  5. Asia-Pacific Monitoring Systems Market By Region, From 2022 - 2027 ( USD Billion )
  6. Asia-Pacific Cannulas Market By Region, From 2022 - 2027 ( USD Billion )
  7. Asia-Pacific Other Components Market By Region, From 2022 - 2027 ( USD Billion )
  8. Asia-Pacific Perfusion Systems Market By Type, From 2022 - 2027 ( USD Billion )
  9. Asia-Pacific Bioreactor Perfusion Systems Market By Region, From 2022 - 2027 ( USD Billion )
  10. Asia-Pacific Microfluidic Perfusion Systems Market By Region, From 2022 - 2027 ( USD Billion )
  11. Asia-Pacific Gravity/Pressure-driven Perfusion Systems Market By Region, From 2022 - 2027 ( USD Billion )
  12. Asia-Pacific Small-mammal Organ Perfusion Systems Market By Region, From 2022 - 2027 ( USD Billion )
  13. Asia-Pacific Perfusion Systems Market By  Technique, From 2022 - 2027 ( USD Billion )
  14. Asia-Pacific Hypothermic Machine Perfusion Systems Market By Region, From 2022 - 2027 ( USD Billion )
  15. Asia-Pacific Normothermic Machine Perfusion Systems Market By Region, From 2022 - 2027 ( USD Billion )
  16. Japan Perfusion Systems Market By Component, From 2022 - 2027 ( USD Billion )
  17. Japan Perfusion Systems Market By Type, From 2022 - 2027 ( USD Billion )
  18. Japan Perfusion Systems Market By  Technique, From 2022 - 2027 ( USD Billion )
  19. China Perfusion Systems Market By Component, From 2022 - 2027 ( USD Billion )
  20. China Perfusion Systems Market By Type, From 2022 - 2027 ( USD Billion )
  21. China Perfusion Systems Market By  Technique, From 2022 - 2027 ( USD Billion )
  22. India Perfusion Systems Market By Component, From 2022 - 2027 ( USD Billion )
  23. India Perfusion Systems Market By Type, From 2022 - 2027 ( USD Billion )
  24. India Perfusion Systems Market By  Technique, From 2022 - 2027 ( USD Billion )
  25. Australia Perfusion Systems Market By Component, From 2022 - 2027 ( USD Billion )
  26. Australia Perfusion Systems Market By Type, From 2022 - 2027 ( USD Billion )
  27. Australia Perfusion Systems Market By  Technique, From 2022 - 2027 ( USD Billion )
  28. South Korea Perfusion Systems Market By Component, From 2022 - 2027 ( USD Billion )
  29. South Korea Perfusion Systems Market By Type, From 2022 - 2027 ( USD Billion )
  30. South Korea Perfusion Systems Market By  Technique, From 2022 - 2027 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample